Osteoporosis Treatment Market Size, Share & Industry Analysis, By Drug Class (Bisphosphonate, Hormone Replacement Therapy, Selective Estrogen Receptor Modulator (SERMs), RANK ligand (RANKL) Inhibitor, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Stores, and Others), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Osteoporosis Treatment Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Osteoporosis Treatment market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Osteoporosis Treatment market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Osteoporosis Treatment Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Osteoporosis Treatment Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Osteoporosis Treatment Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Diverse Product Portfolio and Product Launches of Amgen Inc. and Eli Lilly and Company to Propel the Company Share

The key players dominating the osteoporosis treatment market are Amgen Inc. and Eli Lilly and Company. The companies are dominating market due to its diverse product portfolio and introduction of new products. For instance, a new product named EVENITY by Amgen Inc. was introduced for the treatment of severe osteoporosis is propelling the growth. In terms of revenue, Amgen Inc. holds the dominance owing to its blockbuster product Prolia. The significant upscale of the product across the globe is anticipated to boost the growth of the market during the forecast period. Eli Lilly and Company is a major market player owing to its aim for the development of the osteoporosis drugs along with its blockbuster product like Forteo supporting in terms of revenue.
In addition to this, companies such as Novartis AG and  F. Hoffmann-La Roche Ltd are also focusing on the development of their product portfolio and market penetration. Therefore, the market is expected to experience tough competition over the course of the period.

LIST OF KEY COMPANIES PROFILED:

  
AbbVie Inc.
  
Eli Lilly and Company
  
Amgen Inc.
  
F. Hoffmann-La Roche Ltd
  
Novartis AG
  
Sanofi
  
Pfizer Inc.
  
Merck & Co., Inc.
  
GlaxoSmithKline plc
  
Others

KEY INDUSTRY DEVELOPMENTS:

August 2019 -The biosimilar teriparatide biosimilar named terrosa by GEDEON Richter was launched in Europe after the patent expiry for its reference product. This product is indicated for the treatment of osteoporosis in postmenopausal women and in men with a high risk of fracture along with osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk of fracture.

January  2016 -Taisho Pharmaceutical Co., Ltd., launched anti-inflammatory analgesic patch formulation LOQOA tape for the treatment of osteoarthritis pain inflammation. This tape provides powerful anti-inflammatory analgesic action.

REPORT COVERAGE

The osteoporosis treatment market report provides a detailed analysis of the market and focuses on key aspects such as leading companies, and leading indications of the osteoporosis disorders. Besides this, the report provides key insights into the market trends and highlights major industry developments such as mergers, acquisitions, and collaborations, pipeline analysis, and new product launches.  In addition to this, the report also focuses on the major driving factors and restraints that are influencing the market growth over the course of the period.

Report Scope & Segmentation

Segmentation

By Drug Class

  
Bisphosphonate
  
Hormone Replacement Therapy
  
Selective Estrogen Receptor Modulator (SERMs)
  
RANK ligand (RANKL) Inhibitor
  
Others

By Route of Administration

  
Oral
  
Parenteral

By Distribution Channel

  
Hospitals Pharmacies
  
Retail Pharmacies & Stores
  
Online Pharmacies

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia-Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia- Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)